Last Updated : October 23, 2009
Details
FilesGeneric Name:
Teriparatide (rDNA origin) injection
Project Status:
Complete
Therapeutic Area:
Osteoporosis (in women), Severe
Manufacturer:
Eli Lilly Canada Inc.
Brand Name:
Forteo
Project Line:
Reimbursement Review
Project Number:
SR0180-000
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Drug Plan Initiated
Indications:
Osteoporosis (in women), Severe
Recommendation Type:
Do not list
Final Recommendation:
Files
Last Updated : October 23, 2009